![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, September 19, 2019 6:55:30 PM
Probably depends on the condition being treated. I checked clinicaltrials site for ph3 OM studies and found the following 6 of the first 12 of 91 listed(stopped at 12).
1. Sun Yat-sen University in China. Drug-ulina statin. Projected enrollment 176. Start 1/30/18, est primary completion 12/31/19, est study completion 12/31/22. Estimated start to study completion ~ 3 years- 11 month
2. Soligenex. Drug-SGX942. Projected enrollment 190. Start 12/4/17, est primary completion 3/2020, est study completion 12/2020. Estimated start to study completion ~ 3 years
3. Galera. Drug-GC4419. Projected enrollment 335. Start 10/2018, est primary completion 10/2020, est study completion 10/2024. Note, last update 10/8/18. Estimated start to study completion ~ 6 years.
4. Novartis. Drug- Everolimus(OM for breast cancer patients. Projected enrollment 200. Start 3/26/15, est primary completion 3/31/19, est study completion 5/31/19. Last update 8/2/17. Estimated start to study completion ~ 3 years- 2 months.
5. Zhejiang General Hospital. Drug- Recombinant Human Interlukin-11. Projected enrollment 300. Start 11/11/18, est primary completion 8/31/21, est study completion 8/30/22. Estimated start to study completion ~ 3 years- 9 months.
300 patients seems around normal for ph3 OM study.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM